PATH vs PHGE
Uipath Inc (PATH) versus Biomx Inc (PHGE) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Biomx Inc (PHGE) is a biotechnology company listed on US.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported PHGE revenue for 2026-06-30 was $332.0K. Net income was -$3.8M. PHGE currently screens at market cap $11.5M and trailing P/E 0.0.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. PHGE currently screens at market cap $11.5M and trailing P/E 0.0.
Not investment advice. Open the PATH and PHGE stock pages for the full models.
Not investment advice.